Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000788
Filing Date
2025-01-06
Accepted
2025-01-06 16:45:43
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01062025_090139.html 4  
1 form4-01062025_090139.xml 4 3949
  Complete submission text file 0001415889-25-000788.txt   5433
Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451
Business Address
Hoerter Steven L. (Reporting) CIK: 0001533451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 25511892

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)